Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00015951
Status:
COMPLETED
Last Update Posted:
2019-10-17
First Post:
2001-05-06
Brief Title:
Bevacizumab Cytarabine and Mitoxantrone on Treating Patients With Hematologic Cancers
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Organization Data
Organization:
University of Maryland Baltimore
Class:
OTHER
Study ID:
CDR0000068576
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Maryland Baltimore
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
UM Greenebaum Cancer Center
Collaborators
| Name | Class |
|---|---|
| University of Maryland Greenebaum Cancer Center | OTHER |
| National Cancer Institute NCI | NIH |